Growth Capital For Life Sciences & Healthcare
Telegraph Hill Partners is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives. When you work with us, you get an experienced team that knows how to drive growth and profitability while maintaining the vision and integrity of the organization.
We seek to partner with innovative companies by providing capital and strategic guidance to help them grow.
Latest News & Announcements
Akoya Biosciences Acquires Quantitative Pathology Solutions Portfolio from PerkinElmer
MENLO PARK–(BUSINESS WIRE)—October 31, 2018—Akoya Biosciences (Akoya), a Telegraph Hill Partners (THP) company, has acquired PerkinElmer, Inc’s Quantitative Pathology Solutions (QPS) portfolio. Akoya was founded in 2015 to commercialize the CODEX® multiparameter tissue analysis technology developed [...]
AGENA AND DARUI BIOTECHNOLOGY ANNOUNCE CHINA FDA CLEARANCE OF MASSARRAY TECHNOLOGY FOR DIAGNOSTIC USE IN CHINA
SAN DIEGO, Calif., and GUANGZHOU, China, Wednesday, October 24, 2018 – Agena Bioscience (Agena) and DaRui Biotechnology (DaRui) announced today that the MassARRAY System has formally passed the registration application of Guangdong Food and Drug Administration, becoming the first CFDA approved MALDI [...]
Asuragen Expands Oncology Portfolio with CE Marking and Launch of QuantideX® NGS DNA Hotspot 21 Kit
The panel accurately and sensitively detects over 1600 variants of clinical significance AUSTIN, Texas -- Asuragen, Inc., a molecular diagnostics company delivering high-quality, easy to use products for complex testing in genetics and oncology, today announced the CE marking and launch of the Quant [...]